article thumbnail

Bayer and Evotec link to develop precision cardiology therapeutics

Pharmaceutical Technology

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases (CVDs).

article thumbnail

New training guidance for interventional cardiology

Medical Xpress

The American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions have jointly issued a clinical document outlining competency-based training requirements for interventional cardiology trainees.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NBA Legend Pau Gasol Invests in AI Cardiology Company Idoven

XTalks

Los Angeles Lakers and Spain’s basketball legend Pau Gasol is investing in artificial intelligence (AI) company Idoven , which is developing an AI-powered cardiology service platform. Gasol joins Iker Casillas, Spain’s winning World Cup goalkeeper, as the second athlete to invest in the AI cardiology company.

article thumbnail

Velocity Launches Cardiology Council to Accelerate Research Excellence (CARE)

Velocity Clinical Research

Velocity is proud to unveil another groundbreaking initiative: the Cardiology Council to Accelerate Research Excellence (CARE). Learn more about the Cardiology CARE Council at velocityclinical.com/cardiology-care-council. Heart disease remains the leading cause of death worldwide.

article thumbnail

STAT+: With a potent new medicine, Merck marks a return to cardiology

STAT News

NEW ORLEANS — A new medicine represents a dramatic advance for patients with a rare condition called pulmonary arterial hypertension — and a return to heart disease for Merck, which long had a legendary presence in cardiology. Continue to STAT+ to read the full story…

article thumbnail

UK regulator backs Amarin’s cardiology drug Vazkepa

pharmaphorum

Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The post UK regulator backs Amarin’s cardiology drug Vazkepa appeared first on. Icosapent ethyl also demonstrated a 26% relative risk reduction and a 3.6%

article thumbnail

American College of Cardiology Announces Asia 2022 Conference

Scienmag

Through a shared commitment to transforming cardiovascular care, the American College of Cardiology is partnering with the Korean Society of Cardiology (KSC) to host ACC Asia 2022 Together with KSC Spring Conference, taking place April 15-16, 2022, in Gyeongju, South Korea and virtually. Led by conference co-chairs Fred M.